Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Acerus Pharmaceuticals T.ASP

Alternate Symbol(s):  ASPCD

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
The Market Herald's Weekly Cannabis Report
Affinor Growers (CSE:AFI) announces $2 million private placementSource: Affinor Growers Inc.Affinor Growers Inc. (CSE.AFI, OTCQB: RSSFF, Forum) is undertaking a private placeme... read article.
@ the Bell: Summer blues for TSX, Wall Street sees worst half since 1970
On the last day before the Canada Day long weekend, the TSX finished lower by triple digits in broad-based decline as commodity prices fell. Energy and base metals led decliners, while near 20 per... read article.
Buzz on the Bullboards: Sizzling sector highlights
It has been a sizzling few days recently for most of North America, both weather-wise and for investing discussions. The markets face a rate hike in the U.S., ongoing inflation, rising oil and... read article.

RE:A new poem to commemorate the Acerus Annual General Meeting

Don't give up your day job err - internship........... Curious as to why Ian lent the Company exactly $2.1m............it looks to me like there is another shoe to drop............. still a...read more

A new poem to commemorate the Acerus Annual General Meeting

The poet laureate of the Stockhouse Acerus board, name of Contrarian, has been busy looking for his lost friend Southern Tier Tom, who went missing a couple of weeks ago. But the poet sent me the...read more

New Press Release - Acerus Announces Voting Results for the 2022 Annual Meeting

TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced the voting results from its annual meeting of shareholders held on June 27, 2022. The total number of shares represented in person or by proxy at the meeting was 6,923...read article.

I hope Ed finds room in the last lifeboat off the Titanic

The already-diminished share price is down another 75% recently since the bright idea was raised of consolidating 200 old shares to one. Acerus is afraid to let investors into the AGM tomorrow, and...read more

New Press Release - Acerus Announces Amendments to Loan Facility

TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it has entered into an amending agreement with First Generation Capital Inc. (“First Generation”), a company affiliated with the Chairman of the...read article.

Trading frenzy

With just six days to go until the Acerus AGM, trading volumes are through the roof! Two shares changed hands last Thursday, followed by one share the next day, and zero shares yesterday. To be clear,...read more

RE:RE:RE:RE:RE:Optionality!

Contrarian, you are the poet laureate of the Stockhouse Acerus board, and don't you know it. Hope you don't blow it. "Otherwide Wondered." That is, as you were trying to articulate,...read more

RE:RE:RE:RE:RE:Optionality!

"wandered" that is..........................:)  rate and reply

Ouch PitchinPennies

You've been schooled!  rate and reply

RE:RE:RE:RE:Optionality!

Of course, I shouldn't have expected you to understand.  Optionality has little to do with liqudity.  Optionality has to do with price, volatility, risk free rate of return and time to...read more

RE:RE:RE:Optionality!

Perhaps not since the great e.e. cummings has any poet made such playful use of language. You've got a real gift, my friend. As an example, "Otherwide" may seem to some like a typing...read more

RE:RE:Optionality!

Not a new poem. The same poem.   rate and reply

RE:Optionality!

I see now that I've been looking at the utterances of Contrarian333 entirely the wrong way. The man makes little sense if you're expecting investment commentary, but if you regard him as a...read more

Optionality!

That is all I'm saying, and all I've ever said.  With continued financing that optionality remains intact.  Otherwide not.    rate and reply

thank you PitchinPennies

wow. an outstanding account of our brilliant holdings. very helpful and for now we shall hold.  rate and reply

RE:help please.

Hello, Clangordon and welcome to this board. First off, you can't compare Pfizer with the box of broken toys called Acerus. Pfizer's sildenafil (Viagra) for erectile dysfunction was an...read more

help please.

Been holding for ever; massive losses. As i understand it  insiders control almost the whole float.  Aware that testing has been less then positive. But there is a certain romance to the...read more

Where is all the happy talk?

It's totally unlike C*ntrarian, Southern Turd Tom, and their poodle not to weigh in on this company's wonderful future and genius management team. I mean, just take a look at today's...read more

Understandably afraid to look shareholders in the eye

Just got my invitation to attend the virtual annual meeting on 06/27 at 11 am EDT.  Why virtual? Other public companies have deemed there's limited risk and huge upside to once again ...read more

RE:Hey,

Me! I have! I actually just got paid $1.62 into my cash account "in lieu of" some odd-lot thing related to the share consolidation. This windfall has convinced me that Ian's intentions...read more